Minerva Neurosciences NERV
NASDAQ NERV
$4.43 -0.26 (-5.54%)
At close: Sep 4, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) Current Leases (2019 - 2021)

Minerva Neurosciences' (NERV) quarterly Current Leases came in at $16288.0 in Q2 2021, down 91.19% YoY from $184777.0 in Q2 2020, and down 74.69% on a QoQ basis from $64350.0 in Q1 2021.

Analysis

Minerva Neurosciences (NERV) Current Leases (2019 - 2021) Analysis & Trends

Minerva Neurosciences (NERV) has 3 years of Current Leases data on file, last reported at $16288.0 in Q2 2021.

  • Quarterly Current Leases fell 91.19% year-over-year to $16288.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $16288.0 (down 91.19% YoY) and the FY2020 annual result came in at $111229.0, down 35.67% from the prior year.
  • Current Leases eased to $16288.0 in Q2 2021, from $64350.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $184777.0 in Q2 2020 to a low of $16288.0 in Q2 2021.
  • A 3-year average of $137020.8 and a median of $159279.0 in 2019 frame the typical range for Current Leases.
  • Annual changes were most pronounced in 2020 — Current Leases gained 14.48% — and 2021, when it sank 91.19%.
  • Tracing NERV's Current Leases over 3 years: stood at $172901.0 in 2019, then slumped by 35.67% to $111229.0 in 2020, then plunged by 85.36% to $16288.0 in 2021.
  • The last three Current Leases figures came in at $16288.0 (Q2 2021), $64350.0 (Q1 2021), and $111229.0 (Q4 2020), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 720.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 11.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 16.75 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 21.95 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 45.93 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.27 Mn
10 Minerva Neurosciences 207.37 Mn 207.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 16,288.00
Mar 31, 2021 64,350.00
Dec 31, 2020 111,229.00
Sep 30, 2020 156,956.00
Jun 30, 2020 184,777.00
Mar 31, 2020 178,765.00
Dec 31, 2019 172,901.00
Sep 30, 2019 167,181.00
Jun 30, 2019 161,602.00
Mar 31, 2019 156,159.00